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Depression is frequently experienced by cardiac patients, with a prevalence ranging from
20% to 30% depending on the assessment method, clinical setting, disease severity, and
patient gender, among other factors (1). Even the lower limit of this range is more than
double the prevalence of this treatable condition in the general population (2). Moreover, a
recent Scientific Statement from the American Heart Association (AHA) recommends that
depression be considered a risk factor for adverse medical outcomes among patients with
acute coronary syndrome (ACS), thus giving new urgency to the development and
dissemination of effective and scalable interventions for these high-risk patients (3).
Strategies to treat depression in cardiac patients are of great interest because of their
potential, in theory, to reduce morbidity. While the interventions of earlier trials had only
modest effects on depressive symptoms (4), recent trials of collaborative care (5, 6) and
more intensive treatments (7–9) have demonstrated moderate improvements in depressive
symptoms and health-related quality of life. Although more intensive treatments often
produce gains twice as large as collaborative care interventions (effect size: 0.6 vs. 0.3) (10),
they can be difficult to provide at scale or to patients who have difficulty taking time off
from work, live in rural areas, or have other transportation issues (11). Consequently, the
report by O’Neil and colleagues (12) describing the efficacy and feasibility of a telehealth
intervention for depressed ACS patients in this issue of the Annals is timely.
The MoodCare investigators screened for depression in patients hospitalized for ACS at one
of six Australian hospitals. One hundred twenty-one patients with Patient Health
Questionnaire-9 (PHQ-9) scores of 5–19 (mild to moderately severe symptoms) who were
not already seeing a mental health specialist were enrolled in the trial. Following hospital
discharge, these patients were randomized to either (a) their physicians' usual medical care
or (b) a 6-month telehealth intervention that integrated 10 sessions of cognitive-behavioral
therapy (CBT) for depression delivered by Master’s-level therapists into an existing
cardiovascular disease risk reduction program. At baseline, the mean PHQ-9 score was 9.2.
Half of the enrolled patients had a lifetime history of a depressive disorder, and 16% were
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taking an antidepressant or anxiolytic. At the 6-month follow-up, intervention patients
exhibited significantly greater improvements in depressive symptoms relative to usual care
patients (baseline-adjusted mean difference in post-treatment PHQ-9 score = −1.8 points, p
= .025, effect size = 0.36) but did not display changes in health-related quality of life. The
intervention was also found to be more efficacious for patients with a lifetime history of
depression (mean PHQ-9 difference = −2.7 points, p = .043, effect size = 0.65). The
investigators, however, did not report the impact of their intervention on cardiovascular
morbidity and mortality.
Demonstrating that telephone-delivered CBT is feasible in ACS patients and yields an effect
size similar to other depression interventions in cardiac patients (13) is an important finding.
Because telephone-delivered CBT is likely more scalable, accessible, and cost effective than
traditional CBT, using this approach could increase the number of cardiac patients receiving
evidence-based depression care without a corresponding rise in required resources.
However, the effect size of the MoodCare intervention in the total sample was
approximately half that observed in trials delivering more intensive treatments (7–9).
Possible explanations for this lower efficacy are: (1) patients with minimal or mild
depressive symptoms (53% had a PHQ-9 score < 10) who have little room to improve from
CBT were enrolled, (2) patients with PHQ-9 scores ≥ 20 who may benefit most from
treatment were excluded, (3) depressive symptoms following hospitalization were not
reevaluated to exclude those who experienced a transient elevation in symptoms rather than
a true depressive episode, and (4) adherence to the intervention was lower (61% completed 5
or more of the 10 CBT sessions).
Given the recent AHA Scientific Statement (3) and earlier Scientific Advisory advocating
routine screening and treatment of depression (14), there is a need for future research to
identify ways to optimize approaches to addressing depression in cardiac patients. One
potential approach that could expand treatment delivery at reasonable cost is to incorporate
Internet-delivered computerized CBT (CCBT). At present, these programs are primarily
used in Australia, the United Kingdom, and the Netherlands. When these programs are
provided under the guidance of a non-therapist care manager, they produce depressive
symptom improvements similar to more traditional CBT (effect size: 0.58) (15). Thus,
CCBT could cost-effectively be offered as first-line treatment to all cardiac patients who
screen positive for depression (with or without antidepressants), while reserving specialist-
delivered CBT for nonresponders, those with complicated mental health histories, and others
who lack Internet access.
Another potential and complementary approach is to adopt a prevention focus by
aggressively screening and treating depression earlier in the natural history of cardiovascular
disease, such as in primary care patients with cardiovascular risk factors but no overt
disease. An advantage of earlier treatment with CBT is that it may prevent the onset of a
depressive episode after the occurrence of a cardiac event, as patients treated to remission
with CBT are half as likely to have a recurrence than those treated to remission with
antidepressants (16). Earlier depression treatment may also yield cardiovascular benefits. In
an 8-year follow-up of the Improving Mood-Promoting Access to Collaborative Treatment
(IMPACT) trial, depressed primary care patients without baseline cardiovascular disease
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who were randomized to the collaborative care intervention had a 48% lower risk of a
myocardial infarction or stroke than patients randomized to usual care (17).
In sum, O’Neil et al.’s MoodCare Trial is a valuable step forward in the area of depression
treatment for cardiac patients, as their scalable and accessible intervention could help meet
the likely increasing demand for evidence-based depression care for cardiac patients (3, 14).
At the same time, there remains a need for future research to identify ways to optimize
approaches to addressing depression in this population, which could ultimately result in
improved clinical outcomes for an even larger number of cardiac patients.
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